DE10052658A1 - Neue Pyranosidderivate - Google Patents

Neue Pyranosidderivate

Info

Publication number
DE10052658A1
DE10052658A1 DE10052658A DE10052658A DE10052658A1 DE 10052658 A1 DE10052658 A1 DE 10052658A1 DE 10052658 A DE10052658 A DE 10052658A DE 10052658 A DE10052658 A DE 10052658A DE 10052658 A1 DE10052658 A1 DE 10052658A1
Authority
DE
Germany
Prior art keywords
compounds
formula
propyl
carboximidamide
hydroxyphenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10052658A
Other languages
German (de)
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Franz Birke
Hans Michael Jennewein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to DE10052658A priority Critical patent/DE10052658A1/de
Priority to CA002426564A priority patent/CA2426564A1/en
Priority to AU2002215965A priority patent/AU2002215965A1/en
Priority to EP01988722A priority patent/EP1332151A1/de
Priority to PCT/EP2001/012128 priority patent/WO2002034761A1/de
Priority to JP2002537751A priority patent/JP2004513100A/ja
Priority to MXPA03003466A priority patent/MXPA03003466A/es
Priority to US10/047,526 priority patent/US6528491B2/en
Publication of DE10052658A1 publication Critical patent/DE10052658A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE10052658A 2000-10-24 2000-10-24 Neue Pyranosidderivate Withdrawn DE10052658A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE10052658A DE10052658A1 (de) 2000-10-24 2000-10-24 Neue Pyranosidderivate
CA002426564A CA2426564A1 (en) 2000-10-24 2001-10-19 Pyranoside derivatives
AU2002215965A AU2002215965A1 (en) 2000-10-24 2001-10-19 Pyranoside derivatives
EP01988722A EP1332151A1 (de) 2000-10-24 2001-10-19 Pyranosidderivate
PCT/EP2001/012128 WO2002034761A1 (de) 2000-10-24 2001-10-19 Pyranosidderivate
JP2002537751A JP2004513100A (ja) 2000-10-24 2001-10-19 新規ピラノシド誘導体
MXPA03003466A MXPA03003466A (es) 2000-10-24 2001-10-19 Derivados de piranosido.
US10/047,526 US6528491B2 (en) 2000-10-24 2001-10-23 Pyranoside derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10052658A DE10052658A1 (de) 2000-10-24 2000-10-24 Neue Pyranosidderivate

Publications (1)

Publication Number Publication Date
DE10052658A1 true DE10052658A1 (de) 2002-05-02

Family

ID=7660865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10052658A Withdrawn DE10052658A1 (de) 2000-10-24 2000-10-24 Neue Pyranosidderivate

Country Status (7)

Country Link
EP (1) EP1332151A1 (es)
JP (1) JP2004513100A (es)
AU (1) AU2002215965A1 (es)
CA (1) CA2426564A1 (es)
DE (1) DE10052658A1 (es)
MX (1) MXPA03003466A (es)
WO (1) WO2002034761A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3623368A4 (en) * 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3983272B2 (ja) * 2004-07-14 2007-09-26 有限会社 炎症研究所 腫瘍転移の抑制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19637123A1 (de) * 1996-09-12 1998-03-19 Boehringer Ingelheim Kg Neue Pyranosidderivate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3623368A4 (en) * 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER

Also Published As

Publication number Publication date
AU2002215965A1 (en) 2002-05-06
CA2426564A1 (en) 2002-05-02
JP2004513100A (ja) 2004-04-30
WO2002034761A1 (de) 2002-05-02
EP1332151A1 (de) 2003-08-06
MXPA03003466A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
EP0207331B1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DD221459A5 (de) Verfahren zur herstellung von omeprazolsalzen
EP1203764B1 (de) Benzamidinderivate mit LTB4- antagonistischer Wirkung
EP0823891A1 (de) Acetylsalicylsäurenitrate
DE4321444A1 (de) Pharmazeutische Zubereitung
WO2000020410A1 (de) Mit heterocyclen substituierte propanolaminderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP0931087B1 (de) Neue pyranosidderivate
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
EP0010156B1 (de) 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
EP0029247A1 (de) Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2416491C3 (de) 13.02.74 V.SLVAmerika 442033 Dibenzopyranverbindungen und diese enthaltende Arzneimittel Abbott Laboratories, North Chicago, 111. (V.StA.)
DE10052658A1 (de) Neue Pyranosidderivate
DE602004005048T2 (de) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo ä3.2.1üoctantartrat-salze
EP1222162B1 (de) Neuer ltb4-antagonist, verfahren zu dessen herstellung und dessen verwendung als arzneimittel
EP1332128A1 (de) Benzamidin-derivate mit einer sulfat-gruppe als ltb4-antagonisten
EP1100767B1 (de) Phenylethylaminderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP4093374B1 (de) Komplex aus 7-deacetylforskolin und pvp
EP0498011B1 (de) Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen
DE2606386C3 (de) Arzneimittel mit choleretischer, verdauungsstimulierender und enzymaktivierender Wirkung
WO2008135041A1 (de) Adamantyloxyamin-derivate und verwandte verbindungen als nmda und/oder dpp-4 modulatoren zur behandlung von zns-erkrankungen und diabetes
DE2125113C3 (de) Bis-(4-chlorphenoxy)-essigsäure-(Nmethyl-pyrrolidyl-2)-methylester und dessen Säureanlagerungssalze, Verfahren zu seiner Herstellung sowie diesen enthaltende Arzneimittel
DE60203740T2 (de) Luminacine analoge und deren verwendung
DE1618042C (es)
AT394045B (de) Neue sulfamoyl-thiophene, verfahren zu ihrer herstellung und ihre verwendung
DE2713506A1 (de) Ester der 2- eckige klammer auf 4-(4-chlorbenzoyl)-phenoxy eckige klammer zu -2-methylpropionsaeure mit bis-(hydroxyalkylthio)-alkanen und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, 55218 IN

8139 Disposal/non-payment of the annual fee